[144] DILLARD'S, INC. SEC Filing
Rhea-AI Filing Summary
Dillard's, Inc. (DDS) Form 144 notice reports a proposed sale of 400 Common Class A shares through Charles Schwab (3000 Schwab Way, Westlake, TX) with an aggregate market value of $248,000. The filing shows 11,626,733 shares outstanding and lists an approximate sale date of 09/29/2025 on the NYSE. Acquisition details for the securities to be sold show portions were received as employee compensation on 01/27/2023 (383 shares) and 01/28/2022 (86 shares). The filer also disclosed a recent sale of 100 shares on 09/23/2025 by Christopher B Johnson for $60,124. The notice includes the standard representation that the seller is not aware of undisclosed material information.
Positive
- Disclosure completeness: The Form 144 provides required details including broker, share counts, acquisition dates, and sale date.
- Compliance: The filing appears to satisfy Rule 144 reporting and includes the seller's representation regarding material information.
Negative
- None.
Insights
TL;DR: Routine insider Form 144 disclosing a small proposed sale of DDS shares; no financial performance data provided.
The filing documents a proposed sale of 400 Common Class A shares valued at $248,000, representing a de minimis fraction of the 11.6 million shares outstanding. Acquisition records indicate these shares were granted as employee compensation in 2022 and 2023, which is consistent with routine insider dispositions to monetize compensation. The recent 100-share sale for $60,124 is similarly small in absolute and relative terms. Because the filing contains no operating results, guidance, or material corporate developments, it is informational and unlikely to be material to valuation on its own.
TL;DR: Disclosure complies with Rule 144 requirements; transaction size appears immaterial to shareholders.
The Form 144 furnishes required details: class, broker, quantity, market value, acquisition dates and nature (employee compensation), and recent sales. The signer affirms no undisclosed material information, and the filing cites a planned sale date and exchange. From a governance perspective, this meets standard transparency and insider-trading disclosure obligations. There is no indication of unusual trading patterns or aggregated large dispositions that would raise governance concerns.